$19 assets, $575 price: The structural flaws exposed by the VCX Pre-IPO asset premium frenzy

Original author: @xizhe_chan
On March 19, 2026, @fundrise Innovation Fund (NYSE: VCX) debuted on the New York Stock Exchange at an issuance price of $31.25. Within seven trading days, the stock price peaked at $575, a rise of 1,740% from the issuance price, while its net asset value (NAV) remained around $19, with a peak premium close to 30 times. On March 26, short-selling firm Citron Research released a short report and wrote to the SEC, causing the stock price to plummet about 40% that day.

This article uses the $VCX incident as a core case study, analyzing it from six dimensions: holding structure, comparison with similar products, causes of premium, product nature, rights structure risks, and parallel paths in the crypto market.

The study concludes that the extreme premium of VCX does not stem from expectations of excess returns on underlying assets, but rather from the superposition of three structural factors: extreme scarcity of circulating chips (non-locked shares account for just over 10%), high-intensity endorsement of the AI narrative, and institutional channels' unequal access for retail investors. From the nature of the product, VCX is essentially a financial instrument that sells access qualifications through a compliant shell, and its premium logic fundamentally differs from @MicroStrategy's flywheel mechanism, facing pressure for the access premium to rapidly return to zero after the underlying company completes its IPO.

1. Event Overview: Surge and Plunge in Seven Days

On March 19, 2026, Fundrise Innovation Fund (NYSE: VCX) officially listed on the New York Stock Exchange, with an issuance price set at $31.25 per share. The core selling point of this closed-end fund is simple and direct: it packages equity in top Silicon Valley private tech companies like Anthropic, OpenAI, and SpaceX into a financial product that ordinary investors can freely trade in the secondary market.

However, what happened after the listing was likely unforeseen even by the issuer. On the first day, the closing price rose by 63%, and for the next four trading days, it continued to climb, reaching an intraday high of $575 on March 25, a 1,739% increase from the $31.25 issuance price. Bloomberg reported that as of the close on March 24, VCX was at $314.99, while its underlying asset's NAV was only about $18.97, resulting in a premium multiple of about 16.6 times. By the time it peaked at $575, the market had assigned a premium close to 30 times the underlying assets.

VCX price chart over seven days (March 19 - March 26)

On March 26, the well-known short-selling firm Citron Research announced it was shorting VCX and publicly stated that the fund was trading above $400 despite an asset value of about $19, indicating a severe disconnection. Citron also wrote to the SEC, requesting an investigation into whether Fundrise continued to employ social media influencers, YouTube bloggers, and content publishers to pay for traffic to VCX—based on the fact that Fundrise Advisors LLC had previously been formally penalized by the SEC for failing to disclose compliance after paying about $8 million to over 200 influencers for promotion in 2023. That day, VCX's stock price fell about 40%, dropping from a previous closing price of $380 to about $226, with an intraday low of $182.01.

Key price points for VCX since listing (Data source: Bloomberg, CNBC, investing.com, data as of March 26, 2026, compiled by Go2Mars)

2. Holding Structure: What Exactly Are Investors Buying?

VCX disclosed its top ten holdings as of February 15, 2026, in its prospectus and on the fund's official website. The narrative logic of the entire portfolio is very clear: with Anthropic (20.7%) as the largest position, supplemented by Databricks (17.7%) and OpenAI (9.9%), along with other well-known projects like Anduril, SpaceX, and Epic Games.

However, the issue with the holding structure itself is precisely the most direct irony of this premium. Based on VCX's NAV of about $19, if calculated at the peak market price of $575 on March 25, the market was willing to pay about 30 times the premium for this batch of Pre-IPO equity. In other words, the price paid by investors buying VCX that day, when converted to Anthropic, implied a valuation premium far exceeding its private financing valuation, all occurring within a closed-end fund structure with extremely low liquidity and no direct redemption of holdings.

VCX top ten holdings (as of February 15, 2026)

3. Comparison with Similar Products: Similar Logic, Different Fates

VCX is not an isolated case. In fact, between 2024 and 2026, at least three closed-end funds or similar products focusing on holding equity in private tech companies have been listed in the U.S., showing markedly different market responses.

DXYZ (Destiny Tech100) is the closest reference point to VCX. This fund was listed on the NYSE in March 2024 and initially faced a retail trading frenzy, briefly rising above $100, while its NAV was only about $5 at the time, with a premium close to 2,000%. However, subsequent trajectories have proven that such a premium cannot be maintained long-term: as of March 26, 2026, DXYZ closed at about $29.8, with its latest publicly available NAV at $19.97 (as of December 31, 2025), resulting in a premium of about 50%, significantly narrowed from its peak. The 52-week high was $50.50, still down about 33% from its initial peak.

Comparison of Pre-IPO closed-end funds (as of March 26, 2026)

RVI (Robinhood Ventures Fund I) represents another fate. Also in March 2026, Robinhood launched its own closed-end fund product, priced at $25 per share, with a scale of about $658 million. However, RVI broke below its issue price on the first day, closing at $21, down 16%, contrasting sharply with the exuberance surrounding VCX. As of March 26, 2026, RVI was about $32, with a premium of about 28%, but compared to